InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,460.58
(
1.14%
)
US TECH 100
18,480.40
(
0.82%
)
Dow Jones
40,623.05
(
1.72%
)
Brent Oil
80.01
(
-1.88%
)
Bitcoin
67,507.73
(
2.61%
)
Post# of 252691
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 834
Posts 120125
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biomaven0 post# 143359

Wednesday, 06/06/2012 11:22:31 AM

Wednesday, June 06, 2012 11:22:31 AM

Post# of 252691
Roche’s ADACTA study of Actemra vs Humira under-dosed patients in the Humira arm by giving them 40mg bi-weekly in strict accordance with the FDA label. When Humira is used in RA without methotrexate, as it was in this trial, the de facto dose is 40mg weekly rather than bi-weekly.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up